• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Neuros Medical Inc.

FDA approves electrical nerve stim tech from Neuros Medical

August 28, 2024 By Sean Whooley

Neuros Medical announced today that it received FDA approval for its Altius direct electrical nerve stimulation system. The FDA cleared Altius as an aid in the management of chronic intractable phantom and residual lower limb post-amputation pain in adult amputees. Labeling came on the back of results from the QUEST study, which met all primary […]

Filed Under: Bioelectronic Medicine, Food & Drug Administration (FDA), Implants, Neurological, Neuromodulation/Neurostimulation, Pain Management, Regulatory/Compliance Tagged With: FDA, Neuros Medical Inc.

Neuros Medical raises $37M

November 3, 2020 By Sean Whooley

Neuromodulation technology developer Neuros Medical filed an SEC Form D to confirm the sale of nearly $37 million in equity. Willoughby Hills, Ohio-based Neuros Medical made the first sale in the new notice offering on Oct. 27, 2020, and listed in the SEC filing that it does not intend for it to last longer than […]

Filed Under: Business/Financial News, Funding Roundup, Neurological, Neuromodulation/Neurostimulation, Pain Management Tagged With: Neuros Medical Inc.

Neuros Medical taps ex-Sequent CEO Wilder for corner office | Personnel Moves, August 28, 2017

August 28, 2017 By Brad Perriello

Neuros Medical said it named Tom Wilder, the CEO who led Sequent Medical to a $280 million acquisition by Terumo Corp. (TYO:4543), to take the corner office. “Neuros Medical, with its patented Altius system high-frequency nerve block technology, has the opportunity to develop important therapy options for patients who experience significant pain as a result […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6

Filed Under: Wall Street Beat Tagged With: AdvaMed, EarlySense, Livongo, Masimo, Medovex, Misonix, Neuros Medical Inc., OmniGuide, Personnel Moves, Philips, Proteus Digital Health

Boston Scientific backs Neuros Medical again in $20m round

August 7, 2017 By Brad Perriello

Neuros Medical today said it raised $20 million in what it’s calling a Series AA round, pledging the proceeds to a pivotal study of its Altius neurostimulation technology. Cleveland-based Neuros said the round was led by U.S. Venture Partners and included prior backers Boston Scientific (NYSE:BSX) and JumpStart plus contributions from Aperture Venture Partners and Osage University Partners. Neuros […]

Filed Under: Funding Roundup, Neuromodulation/Neurostimulation, Wall Street Beat Tagged With: Boston Scientific, Neuros Medical Inc.

FDA OKs clinical trial for Neuros Medical’s pain implant

October 10, 2013 By Chris Walker Leave a Comment

FDA OKs clinical trial for Neuros Medical's pain implant

Neuros Medical Inc. said it received an investigational device exemption from the FDA to run a clinical trial of its Altrius implantable generator to treat chronic pain in amputees.

The Altius device, consisting of an electrode and a generator, uses Neuros Medical’s patented electrical nerve block technology to deliver high-frequency stimulation to the peripheral nervous system to block chronic pain.

Filed Under: Food & Drug Administration (FDA), Neuromodulation/Neurostimulation, News Well, Pain Management Tagged With: Clinical Trials, Neuros Medical Inc.

Pain management: Boston Scientific joins Neuros Medical’s $3.5M funding round

July 18, 2012 By MassDevice staff Leave a Comment

Neuros Medical logo

Cleveland, OH- based Neuros Medical announced that it raised $3.5 million in its latest round of funding, with Boston Scientific (NYSE:BSX) and Glengary leading the investment.

Neuros recently received an investigational device exemption from the FDA to evaluate its chronic pain management system, the electrical nerve block, for use in amputee patients to manage pain in the residual limb.

Filed Under: Funding Roundup, News Well, Pain Management Tagged With: Boston Scientific, Glengary LLC, Neuros Medical Inc.

BSX offers 10 year warranties on newly cleared defibrillators | Regulatory Roundup

November 30, 2011 By MassDevice staff Leave a Comment

Boston Scientific's Incepta, Energen and Punctua ICDs

Incepta, Energen and Punctua

Boston Scientific Corp. (NYSE:BSX) landed FDA clearance for its Incepta, Energen and Punctua cardiac implants to treat heart failure and sudden cardiac death.

To go along with the new defibrillator systems, the Natick, Mass.-based med-tech titan is providing an extended warranty for the Incepta and Energen family of defibrillators.

Filed Under: Cardiac Implants, Food & Drug Administration (FDA), Implants, News Well, Stents, Wall Street Beat Tagged With: Abbott, Boston Scientific, Cynosure Inc., Cytori Therapeutics, GE Healthcare, MMAtech Ltd., Neuros Medical Inc., Philips, STAAR Surgical Co, Stent Wars, SweetSpot Diabetes Care Inc., W.L. Gore & Associates

Diabetes: Stratatech lands $4.6 million to study antimicrobial skin graft for diabetic foot ulcers | Funding Roundup

November 1, 2011 By MassDevice staff Leave a Comment

ExpressGraft

Stratatech’s ExpressGraft

Stratatech Corp. won a $4.6 million grant to run a clinical trial from the National Institute of Diabetes & Digestive & Kidney Diseases.

The funds will support the first human study of Stratatech’s ExpressGraft Antimicrobial genetically engineered living skin substitute as a therapy for diabetic foot ulcers.

Filed Under: Funding Roundup, News Well Tagged With: CerviLenz, HyperBranch Medical Technologies, MiMedx Group Inc., Neuros Medical Inc., Sensors for Medicine and Science Inc., Stratatech Corp.

Neuros Medical touts pain-blocking device study | Research roundup

April 6, 2011 By MassDevice staff

Clinical trials roundup

Neurotechnology startup Neuros Medical Inc. reported encouraging results from the first in-human study of its device that blocks pain for amputees.

The Willoughby, Ohio-based company said that four of five patients in the study reported that its device reduced their pain to “zero,” according to a statement from the company.

Filed Under: News Well Tagged With: Aethlon Medical Inc., American College of Cardiology Conference (ACC), Boston Scientific, Clinical Trials, Covidien, ICU Medical Inc., ITGI Medical Ltd., Neuralstem Inc., Neuros Medical Inc.

Northeast Ohio attracts neurotech cluster

January 14, 2011 By MedCity News Leave a Comment

Cleveland Clinic neuromodulation spinoff Intelect Medical may have stealthily exited Cleveland to set up shop in Boston, but the company’s recent $78 million sale to Boston Scientific (NYSE:BSX) highlights Northeast Ohio’s growing strength in neurotechnology.

Filed Under: Business/Financial News, Neurological, Neuromodulation/Neurostimulation, News Well Tagged With: Checkpoint Surgical, Cleveland Clinic, CleveMed, NDI Medical, Neuros Medical Inc., NeuroWave Systems Inc., Synapse Biomedical Inc.

Neuros Medical appoints medical device industry veteran to board

July 12, 2010 By MedCity News Leave a Comment

MedCity News logo

By Brandon Glenn

Neuros Medical Inc. added a medical device industry veteran to its board of directors.

Scott Drees joined the board as an independent director. The Willoughby, Ohio, company is developing a neurostimulation device that uses a pacemaker-sized generator and an electrode to stimulate nerves to block pain from amputations, sometimes called stump pain, without the use of drugs.

Filed Under: Business/Financial News, Neurological, Neuromodulation/Neurostimulation, News Well Tagged With: Neuros Medical Inc.

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy